The study was offered by Drs.

Cell Therapeutics announces preliminary outcomes of stage II OPAXIO research for high-grade gliomas Cell Therapeutics, Inc. The study was offered by Drs. Suriya Jeyapalan, Heinrich Elinzano and Mark Goldman, Assistant Professors of Neurology and Neurosurgery, Dark brown University Oncology Group at the 2010 Scientific Achieving of the Society of Neuro-Oncology in Montreal, Canada metformin for sale online . Regular therapy for patients with malignant mind tumors, like glioblastoma multiforme employs a chemotherapy medication called temozolomide and radiation therapy and outcomes in a PFS of 54 percent at six months.